BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8706889)

  • 1. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors.
    Clauss M; Grell M; Fangmann C; Fiers W; Scheurich P; Risau W
    FEBS Lett; 1996 Jul; 390(3):334-8. PubMed ID: 8706889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha.
    Schmid EF; Binder K; Grell M; Scheurich P; Pfizenmaier K
    Blood; 1995 Sep; 86(5):1836-41. PubMed ID: 7544644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.
    Shen BQ; Lee DY; Cortopassi KM; Damico LA; Zioncheck TF
    J Biol Chem; 2001 Feb; 276(7):5281-6. PubMed ID: 11058594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
    Mechtcheriakova D; Schabbauer G; Lucerna M; Clauss M; De Martin R ; Binder BR; Hofer E
    FASEB J; 2001 Jan; 15(1):230-242. PubMed ID: 11149911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60.
    Weiss T; Grell M; Siemienski K; Mühlenbeck F; Dürkop H; Pfizenmaier K; Scheurich P; Wajant H
    J Immunol; 1998 Sep; 161(6):3136-42. PubMed ID: 9743381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site.
    Weiss T; Grell M; Hessabi B; Bourteele S; Müller G; Scheurich P; Wajant H
    J Immunol; 1997 Mar; 158(5):2398-404. PubMed ID: 9036990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulatory role of PI3-kinase in TNF-induced tumor necrosis.
    Matschurat S; Blum S; Mitnacht-Kraus R; Dijkman HB; Kanal L; De Waal RM; Clauss M
    Int J Cancer; 2003 Oct; 107(1):30-7. PubMed ID: 12925953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells.
    Camera M; Giesen PL; Fallon J; Aufiero BM; Taubman M; Tremoli E; Nemerson Y
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):531-7. PubMed ID: 10073954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells.
    Lazdins JK; Grell M; Walker MR; Woods-Cook K; Scheurich P; Pfizenmaier K
    J Exp Med; 1997 Jan; 185(1):81-90. PubMed ID: 8996244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
    Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D
    J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor effects on nuclear factor-kappaB activation in hematopoietic progenitor cells.
    Dikov MM; Oyama T; Cheng P; Takahashi T; Takahashi K; Sepetavec T; Edwards B; Adachi Y; Nadaf S; Daniel T; Gabrilovich DI; Carbone DP
    Cancer Res; 2001 Mar; 61(5):2015-21. PubMed ID: 11280761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats.
    Heba G; Krzemiński T; Porc M; Grzyb J; Ratajska A; Dembińska-Kieć A
    J Vasc Res; 2001; 38(3):288-300. PubMed ID: 11399901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-induced E-selectin expression on vascular endothelial cells.
    Gedeit RG
    Crit Care Med; 1996 Sep; 24(9):1543-6. PubMed ID: 8797629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects.
    Bikfalvi A; Sauzeau C; Moukadiri H; Maclouf J; Busso N; Bryckaert M; Plouet J; Tobelem G
    J Cell Physiol; 1991 Oct; 149(1):50-9. PubMed ID: 1719003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF protects bovine aortic endothelial cells from TNF-alpha- and H2O2-induced apoptosis via co-modulatory effects on p38-and p42/p44-CCDPK signaling.
    Liu WL; Guo X; Chen QQ; Guo ZG
    Acta Pharmacol Sin; 2002 Jan; 23(1):45-9. PubMed ID: 11860736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals.
    Spyridopoulos I; Brogi E; Kearney M; Sullivan AB; Cetrulo C; Isner JM; Losordo DW
    J Mol Cell Cardiol; 1997 May; 29(5):1321-30. PubMed ID: 9201618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells.
    Kim I; Oh JL; Ryu YS; So JN; Sessa WC; Walsh K; Koh GY
    FASEB J; 2002 Jan; 16(1):126-8. PubMed ID: 11729102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.
    Clauss M; Sunderkötter C; Sveinbjörnsson B; Hippenstiel S; Willuweit A; Marino M; Haas E; Seljelid R; Scheurich P; Suttorp N; Grell M; Risau W
    Blood; 2001 Mar; 97(5):1321-9. PubMed ID: 11222376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.
    Grell M; Douni E; Wajant H; Löhden M; Clauss M; Maxeiner B; Georgopoulos S; Lesslauer W; Kollias G; Pfizenmaier K; Scheurich P
    Cell; 1995 Dec; 83(5):793-802. PubMed ID: 8521496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of NK cells through the 80-kDa TNFR (CD120b).
    Mason AT; McVicar DW; Smith CA; Young HA; Ware CF; Ortaldo JR
    J Leukoc Biol; 1995 Aug; 58(2):249-55. PubMed ID: 7543923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.